The latest edition of EMJ Allergy & Immunology is now live, distilling high-impact insights and the biggest advances from EAACI 2026 ...
During a 17-year stint at Novartis, Carolin Barth, MD, shepherded the development and launches of several antibody therapies that included two blockbuster drugs, Cosentyx® (secukinumab) and Xolair ® ...
Identify research insights to guide research strategy and grow your impact with our Nature Strategy reports. Actionable insights into research performance. Detailed analysis of strengths and ...
AbbVie's multi-billion-dollar Apogee bid could further cement the former's leading position in the immunology space as competition heats up.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results